Acinic cell carcinoma diagnostic study of choice: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
{{CMG}}; {{AE}} {{RG}} | {{CMG}}; {{AE}} {{RG}} | ||
== Overview == | == Overview == | ||
The presence of tumor in parotid gland is first detected by its symptoms and then its consistency is further analysed by CT-scan. Recurrent abnormality of [[Cytogenetics|cytogenetic]] t(12;15) ETV6-NRTK3 is the gold standard test for the diagnosis of acinic cell carcinoma. | |||
== Diagnostic Study of Choice == | == Diagnostic Study of Choice == | ||
Revision as of 15:02, 4 November 2019
|
Acinic cell carcinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case studies |
|
Acinic cell carcinoma diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of Acinic cell carcinoma diagnostic study of choice |
|
Acinic cell carcinoma diagnostic study of choice in the news |
|
Risk calculators and risk factors for Acinic cell carcinoma diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]
Overview
The presence of tumor in parotid gland is first detected by its symptoms and then its consistency is further analysed by CT-scan. Recurrent abnormality of cytogenetic t(12;15) ETV6-NRTK3 is the gold standard test for the diagnosis of acinic cell carcinoma.
Diagnostic Study of Choice
Study of choice
- The presence of tumor in parotid gland is first detected by its symptoms and then its consistency is further analysed by CT-scan. [1]
- Recurrent abnormality of cytogenetic t(12;15) ETV6-NRTK3 is the gold standard test for the diagnosis of acinic cell carcinoma.[2]
References
- ↑ Bussu F, Parrilla C, Rizzo D, Almadori G, Paludetti G, Galli J (2011). "Clinical approach and treatment of benign and malignant parotid masses, personal experience". Acta Otorhinolaryngol Ital. 31 (3): 135–43. PMC 3185824. PMID 22058591.
- ↑ Ripamonti, Carla B; Colombo, Mara; Mondini, Patrizia; Siranoush, Manoukian; Peissel, Bernard; Bernard, Loris; Radice, Paolo; Carcangiu, Maria Luisa (2013). "First description of an acinic cell carcinoma of the breast in a BRCA1 mutation carrier: a case report". BMC Cancer. 13 (1). doi:10.1186/1471-2407-13-46. ISSN 1471-2407.